Janux Therapeutics Strikes Bristol Myers Biotech Deal Worth $800 Million
Janux Therapeutics, Inc. Common Stock · PHARMACEUTICAL PREPARATIONS · Now $14.41
+5.6% in 7d after detection
Post-detection moves
1h
—
1d
+4.3%
3d
+5.1%
7d
+5.6%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS